Knights Felicity, Carter Jessica, Deal Anna, Crawshaw Alison, Bouaddi Oumnia, Sanchez-Clemente Nuria, Seedat Farah, Vanderslott Sam, Eagan Rachel, Holt Daphne E, Ciftci Yusuf, Orcutt Miriam, Seale Holly, Severoni Santino, Hargreaves Sally
The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.
Lancet Reg Health Eur. 2024 May 28;41:100806. doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.
Adult and adolescent migrants worldwide, and those arriving in Europe, are an under-immunised group for routine vaccinations due to missed childhood vaccines and doses in their countries of origin, and their subsequent marginalisation from health and vaccination systems. Declining population-level coverage for routine vaccines across Europe, which has accelerated post-pandemic, places these and other under-immunised populations at even greater risk of vaccine-preventable diseases. However, despite clear guidelines around the importance of delivering 'catch-up' vaccination throughout the life-course, migrants are rarely effectively incorporated into routine vaccination programmes on arrival to Europe. These populations have subsequently been involved in outbreaks, including measles and diphtheria, and are missing opportunities to receive more recently introduced vaccines such as HPV to align them with European vaccine schedules. WHO's new Immunization Agenda 2030 places a renewed emphasis on equitable access to vaccine systems and integrating catch-up vaccination for missed vaccines and doses throughout the life-course. In addition, lessons learned and innovations from the COVID-19 pandemic merit further consideration in the design and delivery of more inclusive vaccination programmes. We describe current gaps in policy and practice around life-course vaccination in migrant populations, key factors that drive low vaccine uptake and coverage, and explore the benefits of participatory approaches to designing and delivering interventions with impacted communities, to define new strategies to advance vaccine equity across the Region.
全球范围内的成年和青少年移民以及抵达欧洲的移民,由于在原籍国错过儿童疫苗接种和剂量,以及随后在健康和疫苗接种系统中被边缘化,成为常规疫苗接种的免疫不足群体。欧洲常规疫苗的人群覆盖率不断下降,在疫情后加速下降,这使这些人群和其他免疫不足人群面临疫苗可预防疾病的更大风险。然而,尽管有明确的指导方针指出在整个生命历程中进行“补种”疫苗接种的重要性,但移民在抵达欧洲后很少能有效地纳入常规疫苗接种计划。这些人群随后卷入了包括麻疹和白喉在内的疫情,并且错过了接种如人乳头瘤病毒(HPV)等最新引入疫苗的机会,无法使其符合欧洲疫苗接种时间表。世界卫生组织新的《2030年免疫议程》再次强调公平获得疫苗系统以及在整个生命历程中整合错过疫苗和剂量的补种疫苗接种。此外,在设计和实施更具包容性的疫苗接种计划时,值得进一步考虑从新冠疫情中吸取的经验教训和创新做法。我们描述了移民人群在整个生命历程疫苗接种方面当前政策和实践中的差距、导致疫苗接种率和覆盖率低的关键因素,并探讨了采用参与式方法与受影响社区共同设计和实施干预措施的益处,以确定在该区域推进疫苗公平性的新策略。